The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
about
Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaNuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantationMetabolic restaging of hepatocellular carcinoma using whole-body F-FDG PET/CT.Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.[(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinomaCT perfusion of the liver: principles and applications in oncology.The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasisPositron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignanciesUpdate of PET and PET/CT for hepatobiliary and pancreatic malignancies.Hepatocellular carcinoma: natural history, current management, and emerging tools.Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesionsHepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinomaPositron emission tomography in hepatobiliary and pancreatic malignancies: a review.Positron emission tomography for staging and assessment of tumor response of hepatic malignancies.Two cases of pulmonary metastasis after living donor liver transplantation for hepatocellular carcinoma.Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
P2860
Q26772334-BD28D3E2-4A80-4325-AD48-11D2BA3FACDFQ33594891-AB9A72E1-F16E-42E9-8DD0-2636E2810514Q34390224-0B909B82-9042-431B-9AC1-80A3A0979333Q34447257-E0E11B76-F88E-440C-98AC-4DF7A7A11F17Q34618851-F53C8893-1898-4969-B248-86421F8AF1A8Q34681040-E0CCF3DC-9422-4E51-B697-AD78B7E91A98Q35154056-8DE2830F-CCF1-4848-B47B-7588DB98F82FQ35156192-2C788ACE-01F5-489A-8142-DA6C44044D26Q35397108-1CC751EF-BCEE-43A3-9DBE-38670862B40AQ36066047-9149D8BA-D821-4A47-96E7-9DB3D337FD55Q36171275-7CAA02B6-C05E-479A-A176-230F967AD488Q36179125-2C37B907-EF2C-4741-BFAB-C9547FC82D82Q36570279-0633CB90-B6F8-4785-BB6E-C3DB30DA1C14Q37034083-1D335A43-209E-4503-B714-CF5BB4D2EAF2Q37037547-8EE016EC-2B03-4ADC-ACF6-7B8FEB16BC63Q37998654-C1F14976-B36B-4999-BBD0-D1D6129B7642Q41951499-A862E5BC-8DAF-475E-AE34-01FCFEB000DCQ48405218-FC9299B5-7A60-4C3E-95E7-5FACB948431FQ49254379-B62CC0E1-9938-4E9D-A192-7C4F264C248B
P2860
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The role of [18F]fluorodeoxygl ...... n of hepatocellular carcinoma.
@ast
The role of [18F]fluorodeoxygl ...... n of hepatocellular carcinoma.
@en
type
label
The role of [18F]fluorodeoxygl ...... n of hepatocellular carcinoma.
@ast
The role of [18F]fluorodeoxygl ...... n of hepatocellular carcinoma.
@en
prefLabel
The role of [18F]fluorodeoxygl ...... n of hepatocellular carcinoma.
@ast
The role of [18F]fluorodeoxygl ...... n of hepatocellular carcinoma.
@en
P2093
P1433
P1476
The role of [18F]fluorodeoxygl ...... on of hepatocellular carcinoma
@en
P2093
C Wright Pinson
David Morris
Dominique Delbeke
L James Wudel
Mary Kay Washington
Michael Rice
William C Chapman
P304
117-24; discussion 124-6
P577
2003-02-01T00:00:00Z